New funding awards - October 2019

Tuesday, November 12, 2019

Sponsored Research

Karen Alexander of Cardiology has received an award (1U19-AG065188-01) from the National Institutes of Health for a project entitled "PREVENTABLE Trial Implementation Phase." Total funding will be $8,238,713.

Karen Alexander of Cardiology has received an award (1U19-AG065188-01) from the National Institutes of Health for a project entitled "PREVENTABLE Administrative and Trial Management." Total funding will be $3,668,978.

Karen Alexander of Cardiology has received an award (1U19-AG065188-01) from the National Institutes of Health for a project entitled "PREVENTABLE Vanguard Phase." Total funding will be $1,862,890.

Karen Alexander of Cardiology has received an award (1U19-AG065188-01) from the National Institutes of Health for a project entitled "PREVENTABLE Protocol Refinement and Study Start-up Phase." Total funding will be $981,241.

Adrian Hernandez of Cardiology has received an award (1U19-AG065188-01) from the National Institutes of Health for a project entitled "PREVENTABLE Clinical Sites Core." Total funding will be $41,760,646.

Adrian Hernandez of Cardiology has received an award (1U24-AT010961-01) from the National Institutes of Health for a project entitled "Collaboratory Resource Coordinating Center for Pragmatic and Implementation Studies for the Management of Pain (PRISM) (U24)." Total funding will be $6,249,316.

Adrian Hernandez of Cardiology has received an award from the Patient-Centered Outcomes Research Institute for a project entitled "PCORnet Phase II TO#15." Total funding will be $411,772.

William Jones of Cardiology has received an award (1U19-AG065188-01) from the National Institutes of Health for a project entitled "PREVENTABLE Recruitment and Retention." Total funding will be $3,533,320.

Yongmei Liu of Cardiology has received an award (7R01-DK101921-05) from the National Institutes of Health for a project entitled "Obesity-Related Epigenetic Changes and Type-2 Diabetes." Total funding will be $436,382.

Kristin Newby of Cardiology has received an award (1U19-AG065188-01) from the National Institutes of Health for a project entitled "PREVENTABLE Biorepository and Laboratory." Total funding will be $3,767,225.

Eric Peterson of Cardiology has received an award from the Society of Thoracic Surgeons for a project entitled "Data Warehousing Center for the Adult Cardiac Surgery, Congenital and Thoracic Databases: Transition Services Agreement." Total funding will be $1.

Jonathan Piccini of Cardiology has received an award from the American Heart Association for a project entitled "Task Order #22 Clinical Insights." Total funding will be $856,092.

Albert Sun of Cardiology has received a sub-award (R34-HL143372-02) through the University of Rochester for a project entitled "FLEC - ARVC." Total funding will be $1.

Diego Bohorquez of Gastroenterology has received an award (1DP2-MH122402-01) from the National Institutes of Health for a project entitled "A gut brain neural circuit relevant to mental illnesses." Total funding will be $2,415,000.

Keisha Bentley-Edwards of General Internal Medicine has received an award (3R01-MD011606-03S1) from the National Institutes of Health for a project entitled "The influence of religion/spirituality on Alzheimer's Disease and it's related dementias (ADRD) for African Americans." Total funding will be $398,857.

Cathleen Colon-Emeric of Geriatrics has received a sub-award (1R01-AG062492-01 Revised) through the Hebrew Rehabilitation Center for a project entitled "Development and Implementation of "Nursing Home Prevention of Injury in Dementia" (NH PRIDE)." Total funding will be $168,424.

Patrick Sullivan of Geriatrics has received a sub-award (1R56-AG061867-01) through the University of Pennsylvania for a project entitled "Sleep and ApoE2 Interactions in Alzheimer Disease." Total funding will be $60,445.

Heather Whitson of Geriatrics has received an award from the Centers for Disease Control and Prevention for a project entitled "IPA-Carl Pieper." Total funding will be $25,837.

Megan Reller of Infectious Diseases has received an award from the Thrasher Research Fund for a project entitled "Effectiveness of PCV-10 to reduce severe viral acute lower respiratory infection in Bangladesh." Total funding will be $437,704.

Xunrong Luo of Nephrology has received an award from the The Henry E. Haller Jr. Foundation for a project entitled "Personalized Transplant Care Research." Total funding will be $575,000.

Opeyemi Olabisi of Nephrology has received an award (1DP2-DK124891-01) from the National Institutes of Health for a project entitled "A Human Stem Cell-Derived Podocyte Model for APOL1 Nephropathy." Total funding will be $2,415,000.

Patrick Pun of Nephrology has received a sub-award (R34-HL140477-02) through the New York University School of Medicine for a project entitled "Reducing Arrhythmia in Dialysis by ADjusting the Rx Electrolytes- RADAR." Total funding will be $135,962.

John Roberts of Nephrology has received an award from the The Henry E. Haller Jr. Foundation for a project entitled "Duke Transplant University: A Digital Patient Education Portal." Total funding will be $115,000.

Myles Wolf of Nephrology has received an award from the The Henry E. Haller Jr. Foundation for a project entitled "Protecting Kidney and Cardiovascular Health long after Kidney Transplant." Total funding will be $1,150,000.

Loretta Que of Pulmonary has received an award from the American Lung Association for a project entitled "Improving Medication Adherence with Telehealthcare Medication Therapy Management to Change Health Outcomes in Adolescents and Young Adults with Asthma (MATCH)." Total funding will be $1.

Industry-sponsored Clinical Trials

Brett Atwater of Cardiology has received an award from Cardialen, Inc. for a project entitled "Cardialen CESS." Total funding will be $78,759.

Melissa Daubert of Cardiology has received an award from HeartFlow, Inc. for a project entitled "Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization." Total funding will be $92,803.

Raymond Kim of Cardiology has received an award from Abiomed for a project entitled "Cardiovascular MR (CMR) Core Lab for the Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction. The STEMI-DTU Pivotal Trial." Total funding will be $1,450,539.

Manesh Patel of Cardiology has received an award from Mytonomy Inc. for a project entitled "Study to Test Risk factor Improvement through Dedicated Education, Engagement, and assessment of patient symptoms in the Cardiac Cath Lab (STRIDE-Cath Lab)." Total funding will be $124,986.

Sreekanth Vemulapalli of Cardiology has received an award from St. Jude Medical Inc. for a project entitled "Association of MitraClip Availability and Hospital Surgical Mitral valve Repair Volume and Mortality." Total funding will be $126,082.

Deepak Voora of Cardiology has received an award from AstraZeneca AB for a project entitled "Identifying on and off-target effects of ticagrelor on megakaryocytic gene expression." Total funding will be $20,632.

Tracy Wang of Cardiology has received an award from Boston Scientific Corporation for a project entitled "Comparative Effectiveness of Left Atrial Appendage Closure versus Under-dosed Anticoagulation for Patients with Non-Valvular Atrial Fibrillation." Total funding will be $56,832.

Danielle Brander of Hematologic Malignancies and Cellular Therapy has received an award from Ascentage Pharma Group for a project entitled "A PHASE I STUDY OF THE SAFETY, TOLERABILITY, PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES OF ORALLY ADMINISTERED APG-2575 IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES." Total funding will be $351,224.

Cristina Gasparetto of Hematologic Malignancies and Cellular Therapy has received an award from Celgene Corporation for a project entitled "A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of BB2121 Versus Standard Triplet Regimens in Subjects with Relapsed and Refractory Multiple Myeloma (RRMM) (KARMMa-3)." Total funding will be $722,257.

David Rizzieri of Hematologic Malignancies and Cellular Therapy has received an award from Mustang Bio for a project entitled "A Phase 1/2, Open Label, Multicenter Trial to Assess the Safety and Efficacy of MB-102 in Patients with Relapsed or Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm, Acute Myeloid Leukemia, and High Risk Myelodysplastic Syndrome." Total funding will be $569,977.

Ara Metjian of Hematology has received an award from Baxalta, Inc. for a project entitled "Phase 3, prospective, randomized, controlled study of prophylatic and on-demand treatment of cTTP with BAX930 (rADAMTS13)." Total funding will be $230,865.

Thomas Ortel of Hematology has received an award from Siemens Healthcare Diagnostics for a project entitled "Siemans/VWF - Hemosil and REAADS Study." Total funding will be $42,512.

Nirmish Shah of Hematology has received an award from Global Blood Therapeutics, Inc. for a project entitled "An Open-Label, Expanded Access Protocol for Patients with Sickle Cell Disease Who Have No Alternative Treatment Options - GBT 440-037." Total funding will be $43,412.

Carey Anders of Medical Oncology has received an award from Angiochem Inc. for a project entitled "A Randomized Open-Label, Multi-Center Pivotal Study of ANG1005 Compared with Physician's Best Choice in HER2-Negative Breast Cancer Patients with Newly Diagnosed Leptomeningeal Carcinomatosis and Previously Treated Brain Metastases (ANGLeD)." Total funding will be $326,422.

Jeffrey Clarke of Medical Oncology has received an award from Adaptimmune Limited for a project entitled "Adaptimmune SURPASS." Total funding will be $472,063.

Jeffrey Crawford of Medical Oncology has received an award from AstraZeneca Pharmaceuticals, LP for a project entitled "A Phase III, Double-blind, Placebo-controlled, Multi-center International Study of Durvalumab plus Chemotherapy Prior to Surgery Followed by Durvalumab Post-surgery Versus Placebo plus Chemotherapy Prior to Surgery Followed by Placebo Post surgery." Total funding will be $1,017,303.

Michael Harrison of Medical Oncology has received an award from AstraZeneca Pharmaceuticals, LP for a project entitled "A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Global Study to Determine the Efficacy and Safety of Durvalumab in Combination with Gemcitabine+Cisplatin (G+C) for Neoadjuvant Treatment and Durvalumab Alone for Adjuvant Treat." Total funding will be $7,000.

Michael Morse of Medical Oncology has received an award from AstraZeneca AB for a project entitled "A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Studyof Transarterial Chemoembolization (TACE) in Combination with either Durvalumab Monotherapy or Durvalumab plus Bevacizumab Therapy in Patients with Locoregional Hepatocellula." Total funding will be $101,501.

Thomas Stinchcombe of Medical Oncology has received an award from Alliance Foundation Trials, LLC for a project entitled "Safety, Activity, and Pharmacology of Nivolumab in Patients with Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease." Total funding will be $244,508.

Tian Zhang of Medical Oncology has received an award from Astellas Pharma Global Development, Inc for a project entitled ""A Multicenter, Open-label, Expanded Access Treatment Protocol of Enfortumab Vedotin in Subjects with Locally Advanced or Metastatic Urothelial Carcinoma (EV-901)" ("Treatment Protocol")." Total funding will be $30,453.

Patricia Lugar of Pulmonary has received an award from Biocryst Corporation for a project entitled "BCX7353-204 An open label study to evaluate the long-term safety of daily oral BCS7353 in subjects with Type I and II hereditary angioedema." Total funding will be $67,839.

Kamran Mahmood of Pulmonary has received an award from Boston Scientific Corporation for a project entitled "IP Fellowship for Kristen Glisinski." Total funding will be $30,030.

Lake Morrison of Pulmonary has received an award from Respivant Sciences, GmbH for a project entitled "Respivant RVT1601-CC-04 SCENIC: Randomized double blind placebo controlled dose ranging efficacy and safety study with inhaled RVT-1601 for the treatment of persistent cough in patients with IPF." Total funding will be $127,541.

Scott Palmer of Pulmonary has received an award from CareDx, Inc. for a project entitled "Cell-free DNA in the Blood and Lung Allograft Fluid: Understanding Association with Acute Rejection in Lung Transplant Recipients." Total funding will be $110,544.